Moreover, the rate of molecular diagnoses (33% vs. 25%) and IUIS-defined IEIs (26.7% vs. 8.3%) was similar, reinforcing that IgM deficiency may span a broader immunological spectrum than currently appreciated (Table 5 and Figure 1A). This evidence concerns the gene CD40LG and hyperinsulinemic hypoglycemia, familial, 4.